PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Wyeth
Wyeth v. Levine: Inside the Preemption Case
Last week, the Supreme Court heard arguments in the long-awaited preemption case, Wyeth v. Levine.
For the first time, the highest court in the land is weighing in on whether federal approval of a drug preempts tort claims against a drugmaker, such as an injured consumer might bring in a state court. A decision for [...]
Posted in Legal, Regulatory Also tagged Congress, FDA, liability, Preemption, Supreme Court, Waxman Leave a comment
Moving On + Up
Promotions and hires for September 26, 2008:
Merck named Barry J. Goldstein, M.D., vice president of clinical development for diabetes and obesity
Sanofi-Aventis announced that Chris Viehbacher will succeed current CEO Gerard Le Fur in December
GlaxoSmithKline named Ellen Strahlman chief medical officer
Questcor Pharmaceuticals appointed Gary Sawka CFO
Encorium appointed David Ginsberg president and CEO
Wyeth named Daniel J. [...]
Posted in People Also tagged announcements, business, communications, Encorium, executives, Ferring, Genesis, GlaxoSmithKline, Lilly, Merck, Merz, new hires, pharmaceutical industry, promotions, Questcor, Sanofi-Aventis, Zafgen, Zosano Leave a comment
Simply Genius: Prix Galien USA 2008 (photos)
Click here to view a slideshow from Prix Galien 2008
The 2008 Prix Galien USA is in the books, and Pharm Exec was in attendance at New York’s Museum of Natural History to take in all the festivities. Pfizer, Merck, Alexion, Wyeth, and Celgene were all recognized for their work in advancing science in both the [...]
Posted in Biotech, Events, People Also tagged Alexion, Biotech, Celgene, Charlie Rose, Elie Wiesel, Merck, Pfizer, Prix Galien Leave a comment
Pfizer to Buy Wyeth for $68 Billion